Target intelligence / Profile preview

DNA, RNA, and protein synthesis machinery

Molecular classification
Other (process), Enzyme (for core individual targets: DNA polymerase, RNA polymerase, ribosome, etc.)
01

Overview

The processes of DNA, RNA, and protein synthesis—often collectively termed "gene expression machinery"—are central to all living cells. DNA synthesis (replication) copies genetic material, RNA synthesis (transcription) converts DNA information into messenger RNA (mRNA), and protein synthesis (translation) decodes mRNA to build proteins, typically at the ribosome. These processes underpin cellular function, heredity, and adaptation, and are targeted by many classes of drugs, including antibiotics, antivirals, and chemotherapies[4][1][6]. Defects or dysregulation in these pathways are central to the development of cancer and numerous genetic diseases.

Other names
gene expression machinerycentral dogma processestranscription/translation machinery
02

Mechanism of action

Inhibition of transcription (e.g., rifampicin blocks bacterial RNA polymerase) Inhibition of translation (e.g., aminoglycosides block ribosomal function) DNA damage and crosslinking (e.g., chemotherapy drugs) Nucleic acid analog incorporation (antivirals/antimetabolites)

03

Biological functions

Cell proliferationCell growthProtein synthesisGenetic information processingCell cycleCellular response to stressApoptosis (when disrupted)
04

Disease associations

Cancer (dysregulation or mutations in these processes are fundamental to oncogenesis)Infection (many anti-microbials target bacterial DNA/RNA/protein synthesis)Antibiotic resistanceGenetic diseases (due to mutations affecting these processes)
05

Safety considerations

Off-target toxicity (many drugs targeting these processes can affect normal rapidly dividing cells, causing myelosuppression, mucositis, hair loss)Mutagenesis (risk of secondary cancers with some DNA-targeting drugs)Antibiotic resistance
06

Interacting drugs

Antibiotics (e.g., tetracyclines, macrolides, aminoglycosides, rifampicin, quinolones—all target bacterial DNA, RNA, or protein synthesis machinery)

2 more in the full profile.

07

Biomarkers

Proliferation markers (e.g., Ki-67, PCNA)DNA/RNA integrity assays (e.g., for drug sensitivity/resistance)Expression of drug resistance genes (e.g., MDR1)

Beyond the preview

Go deeper on DNA, RNA, and protein synthesis machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA, RNA, and protein synthesis machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call